Creditable Coverage
Disclosure to CMS OnLine Form and Instructions (CMS-10198)
Revision of a currently approved collection
No
Regular
02/12/2026
Requested
Previously Approved
36 Months From Approved
12/31/2028
134,351
141,400
11,152
11,784
0
0
Information collection requirements
will ensure that entities that currently provide prescription drug
benefits to any Medicare Part D eligible individual disclose to CMS
whether the prescription drug benefit that they offer is creditable
coverage. The disclosure is required to be provide annually and
upon any change that affects whether the coverage is creditable
prescription drug coverage. This collection also provides
creditable coverage disclosure instructions for entities complying
with these infromation collection request.
This iteration is associated
with our November 28, 2025 (90 FR 54894) proposed rule (CMS-4212-P;
RIN 0938-AV63). The rule estimates that about 5 percent of the
140,974 Group Health Plans (7,049 plans) will no longer be required
to provide disclosure. In this regard we estimate a burden
reduction of minus 7,049 responses, minus 632 hours, and minus
$152,623.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
02/12/2026
Something went wrong when
downloading this file. If you have any questions, please send an
email to risc@gsa.gov.